Immunosuppressants May Reduce Risk of Ocular MG Progressing to gMG

Immunosuppressants May Reduce Risk of Ocular MG Progressing to gMG

297387

Immunosuppressants May Reduce Risk of Ocular MG Progressing to gMG

Treatment with immunosuppressant medications can delay disease progression in patients with ocular myasthenia gravis, which affects only eye muscles, to a more generalized form in which other muscles are affected, a study has found.  The findings also showed that thymus gland abnormalities, as well as irregular results on facial nerve stimulation tests, were both associated with a higher risk of myasthenia gravis (MG) progression. Tests evaluating these parameters should be performed routinely for patients with eye-associated…

You must be logged in to read/download the full post.